Search PubMed⌕ Search

Biomedical subjects

Michael Gross

Publications and source records attributed to Michael Gross.

At least 37 records · Page 2Linked to original sources

Intravascular misplacement of an extravascular closure system: StarClose.

Closure devices for closing femoral arteries following catheterization procedures are routinely used. They reduce time of immobilization and decrease complications such as bleeding and aneurysm formation. We report of a new vascular closure device (StarClose, marketed by Abbott) that was misplaced in the femoral artery with subsequent vascular stenosis and need for surgical removal and plastic reconstruction.

Angiography↗

Doctor "lite".

Explore the source record for details and available documents.

Anatomy, Regional↗

Flu fears escalate.

The new strain of bird flu first identified in southern Asia has now reached Europe, raising local fears about a jump to humans as researchers have controversially reconstructed the deadly Spanish flu virus as a means to determine the factors contributing to its virulence. Michael Gross reports.

Animals↗

Terror firmer.

Explore the source record for details and available documents.

Bioterrorism↗

Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis.

BACKGROUND: Currently, the primary cause of atherosclerosis remains controversial: while oxidized or enzymatically altered LDL is widely accepted as one cause of the inflamed lesion, microorganisms such as C. pneumoniae or cytomegalovirus (CMV) also have recently been postulated to be involved in the pathogenesis of atherosclerosis. Microbial products activate innate immune cells of the host via Toll-like receptors (TLRs). Common polymorphisms of the TLR-2 and TLR-4 genes have been shown to be associated with an increased risk for restenosis after PTCA, and a lower risk of carotid atherosclerosis, respectively. Microbial DNA has been shown to activate immune cells via the cytosolic TLR-9. Specially, C. pneumonia and CMV as intracellular pathogens may be potent trigger of TLR-9 signaling. Therefore, we investigated whether the two common promotor polymorphisms of the TLR-9 gene are correlated with atherogenesis. METHODS: The T-1237C and the T-1486C polymorphisms were analyzed by Real Time PCR in 202 (derivation study, age 58.1, SD 10.0) and 182 (validation study, age 59.7, SD 9.6) patients that underwent angioplasty and 188 healthy controls (age 52.5, SD 6.1). Restenosis was defined as >50% luminal diameter reduction at follow-up angiography. RESULTS: We found the two polymorphism being able to create new potential binding sites for transcription factors, however, no association of the TLR-9 polymorphisms with atherogenesis or restenosis was detectable. CONCLUSION: Our data indicate that the two TLR-9 promotor polymorphisms are not involved in atherogenesis.

Aged↗

A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

Restenosis is a major problem for patients undergoing percutaneous transluminal coronary angioplasty (PTCA). Inflammatory processes and genetic factors have been suggested to be involved in the pathogenesis of both atherosclerosis and restenosis. The recently discovered family of Toll-like receptors (TLRs) consists of molecules that initiate signaling after host-pathogen interactions. Recently it has been shown that the TLRs are involved in the development and progression of atherosclerosis by interfering with lipid metabolisms and by mediating inflammation. TLR-2 is a key innate immunity receptor for sensing both endogenous inflammatory mediators and ligands of several microbial pathogens postulated to be involved in atherosclerosis. A frequent single nucleotide polymorphism (SNP) for the TLR-2 gene, resulting in a non-functional receptor, has been described. By genotyping two independent groups of patients receiving PTCA, followed by stent implantation in one group, we found a significantly enhanced frequency of the TLR-2 Arg753Gln SNP in patients with restenosis as compared to those without restenosis (PTCA: 7.21 versus 2.45%, P = 0.014; PTCA/stent: 6.86 versus 1.53%, P = 0.013). In contrast, a common TLR-4 SNP was similarly distributed among the patient groups investigated. We furthermore compared the frequency of both SNPs in the patients with an age-matched group of individuals without atherosclerosis and found a trend towards a lower frequency of the TLR-4 SNP in the atherosclerotic group (PTCA: 5.58; PTCA/stent: 3.85 versus 7.14%). We conclude that in restenosis a functional TLR-2 is protective and potentially involved in a reaction pattern preventing restenosis. Screening for the TLR-2 Arg753Gln SNP may be of importance for stratifying a patient's risk and for preventive and therapeutic measures.

Coronary Restenosis↗

A new licence to clone.

Many countries are still grappling with the issue of therapeutic cloning of human cells as the UN tackles this issue alongside reproductive cloning, but in the UK a new programme looking at the causes of motor neuron disease has recently been sanctioned. Michael Gross reports.

Amyotrophic Lateral Sclerosis↗

Fears lessen for human BSE.

Alarm bells rang eight years ago with the evidence that mad cow disease could pass from cows to humans via the food chain. But new research suggests that the disease, although still a problem in a number of countries, will have a limited effect on the human population.

Animals↗

Swiss back stem-cell studies.

For the first time ever, a national referendum has decided the fate of stem cell research. Swiss voters have spoken, so their researchers can now get going. Michael Gross reports.

Embryo Research↗

Comparison of osteoblast spreading on microstructured dental implant surfaces and cell behaviour in an explant model of osseointegration. A scanning electron microscopic study.

OBJECTIVES: To compare interactions between rat calvarial osteoblasts and titanium dental implants with different microstructured surfaces. MATERIAL AND METHODS: Seven commercially available implants were used. Surfaces included plasma-sprayed, grit-blasted and/or acid-etched, smooth-machined and anodised titanium. Two methods were used to compare cell behaviour: (1) A cell-spreading assay in which percentages of cells at four different stages of attachment were identified by scanning electron microscopy and quantified within a 30 min attachment period. (2) Implants were placed in 'pocket culture' within nylon mesh sacs in contact with explanted calvarial bone fragments for 2 and 4 weeks. RESULTS: Surfaces combining grit blasting and acid etching, of microporous topography, showed significantly enhanced rates of cell spreading in comparison with the others. Differential cell morphology was observed in both suspension assays and pocket cultures. In the latter, cells migrated onto all surfaces. Multicellular layers with extracellular matrix (ECM) were present between the layers and on the material surfaces after 2 weeks. After 4 weeks, cell layers were more consolidated, and microstructures were obscured by layers of cells and ECM. Mineralised tissue was seen in association with ECM on grit-blasted surfaces of rough and smooth microtopography. CONCLUSIONS: The two methods provided complementary information: a rough surface of porous microstructure may enhance the rate of cell spreading. Differentiation and calcification occurred on surfaces of both rough and smooth microstructure.

Animals↗

Pain relief.

Explore the source record for details and available documents.

Analgesics↗

Polling surgeons.

Explore the source record for details and available documents.

Adrenal Cortex Hormones↗